APA (7th ed.) Citation

Marasco, M., Kumar, D., Garcia Borrego, S., Seale, T., Maddalena, G., Mezzadra, R., . . . Misale, S. (2025). 17P Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations. Annals of Oncology, 36, S214. https://doi.org/10.1016/j.annonc.2025.08.454

Chicago Style (17th ed.) Citation

Marasco, M., et al. "17P Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations." Annals of Oncology 36 (2025): S214. https://doi.org/10.1016/j.annonc.2025.08.454.

MLA (9th ed.) Citation

Marasco, M., et al. "17P Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations." Annals of Oncology, vol. 36, 2025, p. S214, https://doi.org/10.1016/j.annonc.2025.08.454.